A Subsequent New Drug License (SNDL) is a regulatory approval granted for modifications or variations in an existing drug, such as a new dosage form, strength, or route of administration. It ensures safety, efficacy, and quality standards while allowing for advancements and diversification within pharmaceutical offerings.